Ernest Goodpasture and the Mass Production of Vaccines pg. 2
In 1935, in cooperation with the Tennessee State Board of Health, Goodpasture and colleagues vaccinated nearly 1,200 children with the new smallpox vaccine and achieved a remarkable rate of success. But Goodpasture was a basic researcher, and realizing the potential for his landmark discovery, he simply handed the chick embryo technique for growing vaccinia virus over to Upjohn Pharmaceuticals to carry out its commercial production and delivery. Subsequently, the chick embryo technique was also used in the development of vaccines against yellow fever, typhus, influenza and Rocky Mountain spotted fever.
“In my view Goodpasture was an ideal academician,” Collins says. “He chose the profession of medicine because of his desire to understand the mechanisms of disease and thereby reduce the ravaging effects of infections. And he recognized that academic medical institutions were in a particularly advantageous position to benefit mankind.”
The “science, art and humanity” of an affiliated medical school, Goodpasture once stated in a speech, are of great benefit to universities. “Medicine,” he said, “is the most universally accepted example of what education and science can do in the interest of well-being …”
View Related Article:
A Cautionary Tale: New diseases, social factors challenge the victories of vaccines